The Parkinson’s Progression Markers Initiative (PPMI) study has examined whether the finding of normal dopaminergic function with DAT SPECT excludes a diagnosis of PD in those thought to have clinical features—so-called subjects without evidence of dopamine deficiency (SWEDDs). The gene discussed is SLC6A3; the disease is Parkinson disease.